Literature DB >> 18603554

The seventh pathogenic fusion gene FIP1L1-RARA was isolated from a t(4;17)-positive acute promyelocytic leukemia.

Takeshi Kondo, Akio Mori, Stephanie Darmanin, Satoshi Hashino, Junji Tanaka, Masahiro Asaka.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18603554     DOI： 10.3324/haematol.12854

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  34 in total

1.  The leukemic oncoprotein NPM1-RARA inhibits TP53 activity.

Authors:  Erin M Swaney; Anuja Chattopadhyay; Irina Abecassis; Elizabeth A Rush; Robert L Redner
Journal:  Leuk Lymphoma       Date:  2016-01-12

Review 2.  Management of acute promyelocytic leukemia: updated recommendations from an expert panel of the European LeukemiaNet.

Authors:  Miguel A Sanz; Pierre Fenaux; Martin S Tallman; Elihu H Estey; Bob Löwenberg; Tomoki Naoe; Eva Lengfelder; Hartmut Döhner; Alan K Burnett; Sai-Juan Chen; Vikram Mathews; Harry Iland; Eduardo Rego; Hagop Kantarjian; Lionel Adès; Giuseppe Avvisati; Pau Montesinos; Uwe Platzbecker; Farhad Ravandi; Nigel H Russell; Francesco Lo-Coco
Journal:  Blood       Date:  2019-02-25       Impact factor: 22.113

3.  FIP1L1/RARA with breakpoint at FIP1L1 intron 13: a variant translocation in acute promyelocytic leukemia.

Authors:  Juliane Menezes; Francesco Acquadro; Concepción Perez-Pons de la Villa; Félix García-Sánchez; Sara Álvarez; Juan C Cigudosa
Journal:  Haematologica       Date:  2011-07-12       Impact factor: 9.941

4.  Identification of a novel fusion gene, IRF2BP2-RARA, in acute promyelocytic leukemia.

Authors:  C Cameron Yin; Nitin Jain; Meenakshi Mehrotra; Jianhua Zhagn; Alexei Protopopov; Zhuang Zuo; Naveen Pemmaraju; Courtney DiNardo; Cheryl Hirsch-Ginsberg; Sa A Wang; L Jeffrey Medeiros; Lynda Chin; Keyur P Patel; Farhad Ravandi; Andrew Futreal; Carlos E Bueso-Ramos
Journal:  J Natl Compr Canc Netw       Date:  2015-01       Impact factor: 11.908

Review 5.  Current treatment strategy of acute promyelocytic leukemia.

Authors:  Jianqing Mi
Journal:  Front Med       Date:  2011-12-27       Impact factor: 4.592

6.  Role of arsenic trioxide in acute promyelocytic leukemia.

Authors:  Harry J Iland; John F Seymour
Journal:  Curr Treat Options Oncol       Date:  2013-06

Review 7.  Genetic tests to evaluate prognosis and predict therapeutic response in acute myeloid leukemia.

Authors:  Margaret L Gulley; Thomas C Shea; Yuri Fedoriw
Journal:  J Mol Diagn       Date:  2009-12-03       Impact factor: 5.568

Review 8.  Mechanisms of action and resistance to all-trans retinoic acid (ATRA) and arsenic trioxide (As2O 3) in acute promyelocytic leukemia.

Authors:  Akihiro Tomita; Hitoshi Kiyoi; Tomoki Naoe
Journal:  Int J Hematol       Date:  2013-05-14       Impact factor: 2.490

9.  Extrinsic apoptosis is impeded by direct binding of the APL fusion protein NPM-RAR to TRADD.

Authors:  Anuja Chattopadhyay; Brian L Hood; Thomas P Conrads; Robert L Redner
Journal:  Mol Cancer Res       Date:  2014-07-17       Impact factor: 5.852

10.  Comprehensive genomic screens identify a role for PLZF-RARalpha as a positive regulator of cell proliferation via direct regulation of c-MYC.

Authors:  Kim L Rice; Itsaso Hormaeche; Sergei Doulatov; Jared M Flatow; David Grimwade; Ken I Mills; Magdalena Leiva; Julien Ablain; Charuta Ambardekar; Melanie J McConnell; John E Dick; Jonathan D Licht
Journal:  Blood       Date:  2009-10-23       Impact factor: 22.113
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.